Posts Tagged ‘ diabetic macular edema ’
pSivida Corp. Announces Positive Outcome to European Decentralized Procedure for Approval of ILUVIEN® for the Treatment of Chronic Diabetic Macular Edema
WATERTOWN, Mass.--(BUSINESS WIRE)--pSivida announces positive outcome to European Decentralized procedure for approval for ILUVIEN for treatment of chronic diabetic macular edema.
VEGF-Trap Beats Laser Again In Diabetic Macular Edema
Ophthalmology: Several injection protocols were tested against laser for diabetic retinopathy. The 2mg every four weeks protocol demonstrated the best results. All protocols beat laser.
Lucentis Phase III Study Meets Primary Endpoint for Improving Vision in Patients With Diabetic Macular Edema (DME)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, Inc., a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that one of two Phase III studies evaluating monthly Lucentis® (ranibizumab injection) in patients with diabetic macular edema (DME), met its primary endpoint. DME is a serious complication of diabetes that affects up to 10 percent of people with the disease and can lead to blurred vision, severe vision loss and blindness. The study, known as RISE, showed that
Subscribe
